메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
PurposeVaginal intraepithelial neoplasia (VAIN), a rare premalignant condition, is difficult toeradicate. We assess the effectiveness of high-dose rate intracavitary brachytherapy(HDR-ICR) in patients with VAIN or carcinoma in situ (CIS) of the vagina after hysterectomy. Materials and MethodsWe reviewed 34 patients treated for posthysterectomy VAIN or CIS of the vagina bybrachytherapy as the sole treatment. All patients underwent a coloposcopic-directedpunch biopsy or had abnormal cytology, at least 3 consecutive times. All patients weretreated with a vaginal cylinder applicator. The total radiation dose was mainly 40 Gyin 8 fractions during the periods of 4 weeks at a prescription point of the median 0.2 cm(range, 0 to 0.5 cm) depth from the surface of the vaginal mucosa. ResultsAcute toxicity was minimal. Seven patients had grade 1/2 acute urinary and rectalcomplications. There were 15 cases of late toxicity, predominantly vaginal mucosalreaction in 12 patients. Of these patients, two patients suffered from grade 3 vaginalstricture and dyspareunia continuously. After a median follow-up time of 48 months(range, 4 to 122 months), there were 2 recurrences and 2 persistent diseases, inwhich a second-line therapy was needed. The success rate was 88.2%. The averageprescription point in failure patients was 1.1 mm from the surface of the vaginacompared to an average of 2.6 mm in non-recurrent patients (p=0.097). ConclusionHDR-ICR is an effective treatment method in VAIN patients. In spite of high cure rates,we should consider issues regarding vaginal toxicity and radiation techniques toreduce the occurrence of failure and toxicity.

목차

등록된 정보가 없습니다.

참고문헌 (13)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0